(ALLO) Allogene Therapeutics - Performance -57.3% in 12m
Compare ALLO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-94.54%
#190 in Group
Rel. Strength
13.84%
#6856 in Universe
Total Return 12m
-57.25%
#100 in Group
Total Return 5y
-96.47%
#140 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: ALLO (-57.3%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ALLO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ALLO
Total Return (including Dividends) | ALLO | XBI | S&P 500 |
---|---|---|---|
1 Month | -13.24% | 11.81% | 13.81% |
3 Months | -20.27% | -13.61% | -6.30% |
12 Months | -57.25% | -12.29% | 10.65% |
5 Years | -96.47% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | ALLO | XBI | S&P 500 |
1 Month | 16.6% | 72.9% | 83% |
3 Months | -52.2% | -83% | -75.3% |
12 Months | -74.3% | -51.6% | 50.1% |
5 Years | -97.7% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #53 | -22.4% | -23.8% |
3 Month | #46 | -7.71% | -14.9% |
12 Month | #99 | -51.3% | -61.4% |
5 Years | #143 | -95.3% | -98.3% |
FAQs
Does ALLO Allogene Therapeutics outperforms the market?
No,
over the last 12 months ALLO made -57.25%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ALLO made -20.27%, while XBI made -13.61%.
Over the last 3 months ALLO made -20.27%, while XBI made -13.61%.
Performance Comparison ALLO vs Indeces and Sectors
ALLO vs. Indices ALLO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -31.4% | -27.1% | -56.8% | -67.9% |
US NASDAQ 100 | QQQ | -31.6% | -30.6% | -57.0% | -68.9% |
US Dow Jones Industrial 30 | DIA | -31.8% | -23.2% | -56.5% | -65.0% |
German DAX 40 | DAX | -31.3% | -28.2% | -83.0% | -83.0% |
Shanghai Shenzhen CSI 300 | CSI 300 | -33.5% | -25.1% | -57.5% | -64.6% |
Hongkong Hang Seng | HSI | -34.5% | -33.2% | -65.1% | -70.9% |
India NIFTY 50 | INDA | -26.4% | -18.1% | -57.2% | -57.0% |
Brasil Bovespa | EWZ | -32.4% | -30.5% | -65.5% | -48.9% |
ALLO vs. Sectors ALLO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -32.0% | -26.7% | -63.8% | -78.8% |
Consumer Discretionary | XLY | -31.7% | -27.5% | -55.8% | -71.5% |
Consumer Staples | XLP | -30.5% | -19.8% | -63.7% | -66.4% |
Energy | XLE | -31.2% | -20.0% | -50.2% | -47.8% |
Financial | XLF | -32.5% | -26.8% | -63.9% | -79.7% |
Health Care | XLV | -28.4% | -14.1% | -51.8% | -53.2% |
Industrial | XLI | -33.1% | -30.1% | -58.2% | -68.2% |
Materials | XLB | -31.2% | -26.8% | -51.9% | -52.0% |
Real Estate | XLRE | -30.0% | -24.8% | -57.5% | -72.7% |
Technology | XLK | -32.4% | -34.5% | -53.9% | -64.4% |
Utilities | XLU | -31.4% | -22.8% | -64.4% | -74.7% |
Aerospace & Defense | XAR | -33.3% | -34.4% | -68.3% | -84.6% |
Biotech | XBI | -24.8% | -25.1% | -36.6% | -45.0% |
Homebuilder | XHB | -31.8% | -24.7% | -43.6% | -49.7% |
Retail | XRT | -33.3% | -27.9% | -52.5% | -55.8% |